Overview of the viral hepatitis problem
The dawn of a new era: Transforming our domestic response to hepatitis B & C

Authors: Lok, A.S.F., Kim, W.R., El-Serag, H.B., Maddrey, W.C.

Source: JOURNAL OF FAMILY PRACTICE. 59(4):S11-S16

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN075910720&indx=1&recIds=ETOCCN075910720

Treatment strategies for hepatitis B in the West
Chronic inflammation of liver and gut

Authors: Lok, A.S.F.

Source: FALK SYMPOSIUM. 163:87-95

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN070863520&indx=1&recIds=ETOCCN070863520

How To Diagnose and Treat Hepatitis B Virus Antiviral Drug Resistance in the Liver Transplant Setting
American Association for the Study of Liver Diseases & International Liver Transplantation Society transplant course meeting; Liver transplant for viral hepatitis and fulminant hepatic failure

Authors: Lok, A.S.F.

Source: LIVER TRANSPLANTATION -PHILADELPHIA-. 14(10):S8-S14

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN070437800&indx=1&recIds=ETOCCN070437800

Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL Cohort

Authors: Kulik, L.M., Fisher, R.A. ^*, Rodrigo, D.R., Brown, R.S., Jr., Freise, C.E., Shaked, A., Everhart, J.E., Everson, G.T., Hong, J.C., Hayashi, P.H., Berg, C.L., Lok, A.S.F.

Source: In American Journal of Transplantation November 2012 12(11):2997-3007

Variation in Organ Quality between Liver Transplant Centers

Authors: Volk, M.L. ^*, Reichert, H.A., Lok, A.S.F., Hayward, R.A.

Source: In American Journal of Transplantation May 2011 11(5):958-964

Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation

Authors: Degertekin, B., Han, Steven-Huy B., Keeffe, E.B, Schiff, E.R, Luketic, V.A, Brown, Jr., R.S, Emre, S., Soldevila-Pico, C., Reddy, K.R, Ishitani, M.B, Tran, T.T, Pruett, T.L, Lok, A.S.F ^*

Source: In American Journal of Transplantation August 2010 10(8):1823-1833

New Pharmacologic Therapies in Chronic Hepatitis B
Clinical Pharmacology of Gastrointestinal and Liver Disease

Authors: Hongthanakorn, C., Lok, A.S.F.

Source: GASTROENTEROLOGY CLINICS OF NORTH AMERICA. 39(3):659-680

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN282378620&indx=1&recIds=ETOCRN282378620

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C

Authors: Fontana, R.J., Dienstag, J.L., Bonkovsky, H.L., Sterling, R.K., Naishadham, D., Goodman, Z.D., Lok, A.S.F., Wright, E.C., Su, G.L., HALT-C Trial Group

Source: GUT. 59(10):1401-1409

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN278772949&indx=1&recIds=ETOCRN278772949

Hepatitis B: Liver fibrosis and hepatocellular carcinoma

Authors: Lok, A.S.F.

Source: GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE. 33(10/11):911-915

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN261282640&indx=1&recIds=ETOCRN261282640

Update on viral hepatitis: 2008

Authors: Degertekin, B., Lok, A.S.F.

Source: CURRENT OPINION IN GASTROENTEROLOGY. 25(3):180-185

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN249801688&indx=1&recIds=ETOCRN249801688

Management of Incidental HCV Infection

Authors: Afdhal, N.H., Lok, A.S.F., Di Bisceglie, A.M.

Source: NEW ENGLAND JOURNAL OF MEDICINE. 360(18):1902-1906

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN249310679&indx=1&recIds=ETOCRN249310679

Update on viral hepatitis: 2007

Authors: Degertekin, B., Lok, A.S.F.

Source: CURRENT OPINION IN GASTROENTEROLOGY. 24(3):306-311

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN228092060&indx=1&recIds=ETOCRN228092060

Recipient Morbidity After Living and Deceased Donor Liver Transplantation: Findings from the A2ALL Retrospective Cohort Study

Authors: Freise, C.E. ^*, Gillespie, B.W., Koffron, A.J., Lok, A.S.F., Pruett, T.L., Emond, J.C., Fair, J.H., Fisher, R.A., Olthoff, K.M., Trotter, J.F., Ghobrial, R.M., Everhart, J.E.

Source: In American Journal of Transplantation December 2008 8(12):2569-2579

Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver Transplantation

Authors: Fisher, R.A. ^*, Kulik, L.M., Freise, C.E., Lok, A.S.F., Shearon, T.H., Brown, R.S., Jr, Ghobrial, R.M., Fair, J.H., Olthoff, K.M., Kam, I., Berg, C.L.

Source: In American Journal of Transplantation June 2007 7(6):1601-1608

Does Antiviral Therapy Prevent Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Liver Resection?

Authors: Lok, A.S.F.

Source: JOURNAL- AMERICAN MEDICAL ASSOCIATION. 308(18):1922-1924

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN323022872&indx=1&recIds=ETOCRN323022872

Reactivation of Hepatitis B During Immunosuppressive Therapy: Potentially Fatal Yet Preventable

Authors: Lok, A.S.F., Ward, J.W., Perrillo, R.P., McMahon, B.J., Liang, T.J.

Source: ANNALS OF INTERNAL MEDICINE. 156(10):743-745

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN312362623&indx=1&recIds=ETOCRN312362623

Hepatitis C after renal transplantation

Authors: Chan, T.M ^*, Lok, A.S.F, Lai, C.L, Cheng, I.K.P, Lai, K.N

Source: In Transplantation Proceedings 2000 32(7):1799-1800

P0460 : CD3hiCD4- Vγ9/Vδ2 TCR+ gamma delta T cells with Th1 and NK-like phenotype are induced in patients with chronic hepatitis B

Authors: Park, J.-J., Traum, D., Ho, S., Wahed, A.S., Johnson, G., Ojiro, K., Wong, D.K., Lee, W.M., Terrault, N., Khalili, M., Sterling, R.K., Kowdley, K.V., Lau, D.T., Roberts, L.R., Smith, C., Carithers, R.L., Levine, D.L., Keith, J., Valiga, M.E., Betts, M., Janssen, H., Lok, A.S.F., Chang, K.-M.

Source: In Journal of Hepatology April 2015 62 Supplement 2:S485-S485

P163 IMMUNE CORRELATES OF VACCINE-MEDIATED PROTECTIVE IMMUNITY VERSUS VIRAL PERSISTENCE IN HEPATITIS B VIRUS INFECTION

Authors: Park, J.-J., Wong, D.K., Wahed, A.S., Lee, W.M., Feld, J.J., Terrault, N., Khalili, M., Kowdley, K.V., Lau, D.T., Sterling, R.K., Kim, W.R., Smith, C., Carithers, R., Levine, D.L., Keith, J., Valiga, M.E., Lok, A.S.F., Chang, K.-M.

Source: In Journal of Hepatology April 2014 60(1) Supplement:S120-S120

Prevention of hepatitis B virus-related hepatocellular carcinoma

Authors: Lok, A.S.F.

Source: Gastroenterology; November 2004, Vol. 127 Issue: 5, Supplement 1 pS303-S309, 7p